(-)-epigallocatechin 3-gallate multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GCNT2 mRNA CTD PMID:22079256 (S)-nicotine increases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in increased expression of GCNT2 mRNA CTD PMID:17997037 (S)-nicotine decreases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in decreased expression of GCNT2 mRNA CTD PMID:21955143 1,2-dimethylhydrazine increases expression ISO Gcnt2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of GCNT2 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA CTD PMID:20823114 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Gcnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of GCNT2 mRNA CTD PMID:15800033 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GCNT2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Gcnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of GCNT2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GCNT2 mRNA CTD PMID:21215274 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Gcnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GCNT2 promoter] CTD PMID:19654925 2,4-dinitrobenzenesulfonic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 2 and 4-dinitrobenzenesulfonic acid results in increased expression of GCNT2 mRNA CTD PMID:30116771 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of GCNT2 mRNA CTD PMID:28300664 3,4-methylenedioxymethamphetamine increases expression ISO Gcnt2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GCNT2 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO Gcnt2 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of GCNT2 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases methylation ISO Gcnt2 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of GCNT2 exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO Gcnt2 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GCNT2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO Gcnt2 (Mus musculus) 6480464 Fenretinide results in increased expression of GCNT2 mRNA CTD PMID:28973697 5-azacytidine decreases expression ISO GCNT2 (Homo sapiens) 6480464 Azacitidine results in decreased expression of GCNT2 mRNA CTD PMID:20823114 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GCNT2 mRNA CTD PMID:25825206 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GCNT2 mRNA CTD PMID:30047161 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GCNT2 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO Gcnt2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of GCNT2 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 Tretinoin results in increased expression of GCNT2 mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO GCNT2 (Homo sapiens) 6480464 Tretinoin results in increased expression of GCNT2 mRNA CTD PMID:33167477 all-trans-retinoic acid multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA more ... CTD PMID:30951980 amitrole increases expression EXP 6480464 Amitrole results in increased expression of GCNT2 mRNA CTD PMID:30047161 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of GCNT2 mRNA CTD PMID:30779732 arsane decreases expression ISO Gcnt2 (Mus musculus) 6480464 Arsenic results in decreased expression of GCNT2 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO Gcnt2 (Mus musculus) 6480464 Arsenic results in decreased expression of GCNT2 mRNA CTD PMID:19654921 arsenite(3-) increases methylation ISO GCNT2 (Homo sapiens) 6480464 arsenite results in increased methylation of GCNT2 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression ISO Gcnt2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of GCNT2 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO GCNT2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of GCNT2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO GCNT2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of GCNT2 5' UTR and Benzo(a)pyrene affects the methylation of GCNT2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO GCNT2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of GCNT2 mRNA CTD PMID:20106945 and PMID:21632981 benzo[a]pyrene increases expression ISO Gcnt2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of GCNT2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GCNT2 mRNA CTD PMID:21839799 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GCNT2 mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GCNT2 mRNA CTD PMID:33296240 and PMID:34947998 bisphenol A increases expression ISO Gcnt2 (Mus musculus) 6480464 bisphenol A results in increased expression of GCNT2 mRNA CTD PMID:30951980 and PMID:32156529 bisphenol A multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GCNT2 gene CTD PMID:28505145 bisphenol F multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO Gcnt2 (Mus musculus) 6480464 bisphenol F results in increased expression of GCNT2 mRNA CTD PMID:30951980 bortezomib increases expression ISO GCNT2 (Homo sapiens) 6480464 Bortezomib results in increased expression of GCNT2 mRNA CTD PMID:20977926 bucladesine multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA CTD PMID:20823114 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GCNT2 mRNA CTD PMID:25993096 carbon nanotube affects expression ISO Gcnt2 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of GCNT2 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO Gcnt2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of GCNT2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO GCNT2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to GCNT2 gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO Gcnt2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of GCNT2 mRNA CTD PMID:37019170 chromium(6+) decreases expression ISO GCNT2 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of GCNT2 mRNA CTD PMID:30690063 cisplatin affects response to substance ISO GCNT2 (Homo sapiens) 6480464 GCNT2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cocaine increases expression ISO Gcnt2 (Mus musculus) 6480464 Cocaine deficiency results in increased expression of GCNT2 mRNA CTD PMID:27126842 copper(II) sulfate increases expression ISO GCNT2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of GCNT2 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of GCNT2 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO GCNT2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of GCNT2 mRNA CTD PMID:25562108 cytarabine decreases expression ISO GCNT2 (Homo sapiens) 6480464 Cytarabine results in decreased expression of GCNT2 mRNA CTD PMID:21198554 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of GCNT2 mRNA CTD PMID:23640034 dexamethasone increases expression ISO Gcnt2 (Mus musculus) 6480464 Dexamethasone results in increased expression of GCNT2 mRNA CTD PMID:22733784 diazinon increases methylation ISO GCNT2 (Homo sapiens) 6480464 Diazinon results in increased methylation of GCNT2 gene CTD PMID:22964155 diuron decreases expression EXP 6480464 Diuron results in decreased expression of GCNT2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO GCNT2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of GCNT2 mRNA CTD PMID:29803840 emodin increases expression ISO Gcnt2 (Mus musculus) 6480464 Emodin results in increased expression of GCNT2 mRNA CTD PMID:15612046 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GCNT2 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO Gcnt2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of GCNT2 mRNA CTD PMID:35436446 ethanol decreases expression ISO Gcnt2 (Mus musculus) 6480464 Ethanol results in decreased expression of GCNT2 mRNA CTD PMID:21955143 ethyl methanesulfonate decreases expression ISO GCNT2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of GCNT2 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO GCNT2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of GCNT2 mRNA CTD PMID:20655997 and PMID:23649840 furan increases expression ISO Gcnt2 (Mus musculus) 6480464 furan results in increased expression of GCNT2 mRNA CTD PMID:24183702 glafenine increases expression EXP 6480464 Glafenine results in increased expression of GCNT2 mRNA CTD PMID:24136188 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of GCNT2 mRNA CTD PMID:24915197 inulin multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCNT2 mRNA CTD PMID:36331819 isoprenaline increases expression ISO Gcnt2 (Mus musculus) 6480464 Isoproterenol results in increased expression of GCNT2 mRNA CTD PMID:20003209 kainic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 Kainic Acid results in increased expression of GCNT2 mRNA CTD PMID:17997037 medroxyprogesterone acetate multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA CTD PMID:20823114 methimazole increases expression EXP 6480464 Methimazole results in increased expression of GCNT2 mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO GCNT2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of GCNT2 mRNA CTD PMID:23649840 morphine increases expression ISO Gcnt2 (Mus musculus) 6480464 Morphine results in increased expression of GCNT2 mRNA CTD PMID:21955143 morphine decreases expression ISO Gcnt2 (Mus musculus) 6480464 Morphine deficiency results in decreased expression of GCNT2 mRNA CTD PMID:27126842 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of GCNT2 mRNA CTD PMID:19638242 nickel sulfate increases expression ISO GCNT2 (Homo sapiens) 6480464 nickel sulfate results in increased expression of GCNT2 mRNA CTD PMID:22714537 nicotine increases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in increased expression of GCNT2 mRNA CTD PMID:17997037 nicotine decreases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in decreased expression of GCNT2 mRNA CTD PMID:21955143 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of GCNT2 mRNA CTD PMID:26720608 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GCNT2 mRNA CTD PMID:25729387 ozone increases expression ISO Gcnt2 (Mus musculus) 6480464 Ozone results in increased expression of GCNT2 mRNA CTD PMID:19555225 paracetamol decreases expression ISO GCNT2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of GCNT2 mRNA CTD PMID:21420995 and PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GCNT2 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid affects expression ISO Gcnt2 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of GCNT2 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCNT2 mRNA CTD PMID:36331819 perfluorooctanoic acid affects expression ISO Gcnt2 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of GCNT2 mRNA CTD PMID:19429403 phenobarbital affects expression ISO Gcnt2 (Mus musculus) 6480464 Phenobarbital affects the expression of GCNT2 mRNA CTD PMID:23091169 pirinixic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 pirinixic acid results in increased expression of GCNT2 mRNA CTD PMID:17426115 and PMID:18445702 pirinixic acid decreases expression ISO Gcnt2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of GCNT2 mRNA CTD PMID:23811191 potassium chromate multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GCNT2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO GCNT2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of GCNT2 mRNA CTD PMID:22079256 and PMID:22714537 pravastatin increases expression ISO Gcnt2 (Mus musculus) 6480464 Pravastatin results in increased expression of GCNT2 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of GCNT2 mRNA CTD PMID:27225895 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of GCNT2 mRNA CTD PMID:30047161 quercetin decreases expression ISO GCNT2 (Homo sapiens) 6480464 Quercetin results in decreased expression of GCNT2 mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO Gcnt2 (Mus musculus) 6480464 Oxyquinoline results in increased expression of GCNT2 mRNA CTD PMID:15612046 resveratrol multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of GCNT2 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA CTD PMID:27188386 silver atom increases expression ISO GCNT2 (Homo sapiens) 6480464 Silver results in increased expression of GCNT2 mRNA CTD PMID:26014281 silver(0) increases expression ISO GCNT2 (Homo sapiens) 6480464 Silver results in increased expression of GCNT2 mRNA CTD PMID:26014281 sodium arsenite increases expression ISO Gcnt2 (Mus musculus) 6480464 sodium arsenite results in increased expression of GCNT2 mRNA CTD PMID:18812580 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GCNT2 mRNA CTD PMID:35314868 Soman increases expression EXP 6480464 Soman results in increased expression of GCNT2 mRNA CTD PMID:19281266 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of GCNT2 mRNA CTD PMID:25905778 sunitinib decreases expression ISO GCNT2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of GCNT2 mRNA CTD PMID:31533062 temozolomide increases expression ISO GCNT2 (Homo sapiens) 6480464 Temozolomide results in increased expression of GCNT2 mRNA CTD PMID:31758290 testosterone increases expression ISO Gcnt2 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of GCNT2 mRNA CTD PMID:33848595 tetrachloromethane affects expression ISO Gcnt2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of GCNT2 mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GCNT2 mRNA CTD PMID:31150632 thalidomide decreases expression ISO Gcnt2 (Mus musculus) 6480464 Thalidomide results in decreased expression of GCNT2 mRNA CTD PMID:26217789 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GCNT2 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GCNT2 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of GCNT2 mRNA CTD PMID:25729387 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of GCNT2 mRNA CTD PMID:30589522 valproic acid affects expression ISO GCNT2 (Homo sapiens) 6480464 Valproic Acid affects the expression of GCNT2 mRNA CTD PMID:25979313 vanadyl sulfate increases expression ISO GCNT2 (Homo sapiens) 6480464 vanadyl sulfate results in increased expression of GCNT2 mRNA CTD PMID:16330358 vorinostat multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA CTD PMID:27188386 zaragozic acid A affects expression ISO Gcnt2 (Mus musculus) 6480464 squalestatin 1 affects the expression of GCNT2 mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of GCNT2 mRNA CTD PMID:27225895 zinc atom multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of GCNT2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of GCNT2 mRNA CTD PMID:18593933
